Corvus Pharmaceuticals, Inc. entered into an Amended and Restated Open Market Sale Agreement SM on March 13, 2026. The agreement is filed as Exhibit 1.1.
Key takeaways
Entered into Amended and Restated Open Market Sale Agreement SM on 2026-03-13
Agreement with the Company
Exhibit 1.1: Amended and Restated Open Market Sale Agreement SM dated 2026-03-13